Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The most commonly prescribed options include GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), which are FDA-approved specifically for chronic weight management
What do GLPs not do
Stimulation of insulin secretion and insulin gene expression by gastric inhibitory polypeptide
User reviews comparing both drugs Real-world feedback echoes the clinical data, with many people praising tirzepatides rapid results and manageable side effects
US$ 25.03
US$ 22.69
US$ 21.28
US$ 29.86
US$ 21.25
